{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:59:09Z","timestamp":1790027949430,"version":"4.0.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"18","license":[{"start":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T00:00:00Z","timestamp":1547424000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T00:00:00Z","timestamp":1547424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA201335"],"award-info":[{"award-number":["CA201335"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA046592-26S3"],"award-info":[{"award-number":["CA046592-26S3"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA17483601"],"award-info":[{"award-number":["CA17483601"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009779","name":"Bladder Cancer Advocacy Network","doi-asserted-by":"publisher","award":["YIA"],"award-info":[{"award-number":["YIA"]}],"id":[{"id":"10.13039\/100009779","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006293","name":"American Society of Clinical Oncology","doi-asserted-by":"publisher","award":["YIA"],"award-info":[{"award-number":["YIA"]}],"id":[{"id":"10.13039\/100006293","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1038\/s41388-018-0646-9","type":"journal-article","created":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T18:02:44Z","timestamp":1547488964000},"page":"3340-3354","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["ATDC mediates a TP63-regulated basal cancer invasive program"],"prefix":"10.1038","volume":"38","author":[{"given":"Phillip L.","family":"Palmbos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armand","family":"Bankhead III","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan J.","family":"Kelleher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huibin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"McKenzie L.","family":"Ahmet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica R.","family":"Gumkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel D.","family":"Welling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Magnuson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Leflein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8423-3279","authenticated-orcid":false,"given":"Guadalupe","family":"Lorenzatti Hiles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan V.","family":"Abel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele L.","family":"Dziubinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumithra","family":"Urs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark L.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats E.","family":"Ljungman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane M.","family":"Simeone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,14]]},"reference":[{"key":"646_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332.","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7\u201330. \n                    https:\/\/doi.org\/10.3322\/caac.21332.","journal-title":"CA Cancer J Clin"},{"key":"646_CR2","doi-asserted-by":"publisher","unstructured":"Network, T. C. G. A. R. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature \n                    https:\/\/doi.org\/10.1038\/nature12965\n                    \n                   (2014).","DOI":"10.1038\/nature12965"},{"key":"646_CR3","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1073\/pnas.1318376111.","volume":"111","author":"JS Damrauer","year":"2014","unstructured":"Damrauer JS, et al. Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology. Proc Natl Acad Sci USA. 2014;111:3110\u20135. \n                    https:\/\/doi.org\/10.1073\/pnas.1318376111.","journal-title":"Proc Natl Acad Sci USA"},{"key":"646_CR4","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ccr.2014.01.009.","volume":"25","author":"W Choi","year":"2014","unstructured":"Choi W, et al. Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell. 2014;25:152\u201365. \n                    https:\/\/doi.org\/10.1016\/j.ccr.2014.01.009.","journal-title":"Cancer Cell"},{"key":"646_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ccell.2016.05.004.","volume":"30","author":"J Hedegaard","year":"2016","unstructured":"Hedegaard J, et al. Comprehensive transcriptional analysis of early-stage urothelial carcinoma. Cancer Cell. 2016;30:27\u201342. \n                    https:\/\/doi.org\/10.1016\/j.ccell.2016.05.004.","journal-title":"Cancer Cell"},{"key":"646_CR6","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1158\/1078-0432.CCR-12-0077-T.","volume":"18","author":"G Sj\u00f6dahl","year":"2012","unstructured":"Sj\u00f6dahl G, et al. A molecular taxonomy for urothelial carcinoma. Clin Cancer Res. 2012;18:3377\u201386. \n                    https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-0077-T.","journal-title":"Clin Cancer Res"},{"key":"646_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3233\/BLC-150037.","volume":"2","author":"SP Lerner","year":"2016","unstructured":"Lerner SP, et al. Bladder cancer molecular taxonomy: summary from a consensus meeting. Bladder Cancer. 2016;2:37\u201347. \n                    https:\/\/doi.org\/10.3233\/BLC-150037.","journal-title":"Bladder Cancer"},{"key":"646_CR8","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.eururo.2017.03.010.","volume":"72","author":"W Choi","year":"2017","unstructured":"Choi W, et al. Genetic alterations in the molecular subtypes of bladder cancer: illustration in the cancer genome atlas dataset. Eur Urol. 2017;72:354\u201365. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2017.03.010.","journal-title":"Eur Urol"},{"key":"646_CR9","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","volume":"171","author":"AG Robertson","year":"2017","unstructured":"Robertson AG, et al. Comprehensive molecular characterization of muscle-invasive bladder cancer. Cell. 2017;171:540 \n                    https:\/\/doi.org\/10.1016\/j.cell.2017.09.007\n                    \n                  . e525.","journal-title":"Cell"},{"key":"646_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/path.4886.","volume":"242","author":"G Sjodahl","year":"2017","unstructured":"Sjodahl G, Eriksson P, Liedberg F, Hoglund M. Molecular classification of urothelial carcinoma: global mRNA classification versus tumour-cell phenotype classification. J Pathol. 2017;242:113\u201325. \n                    https:\/\/doi.org\/10.1002\/path.4886.","journal-title":"J Pathol"},{"key":"646_CR11","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.cell.2014.06.049.","volume":"158","author":"KA Hoadley","year":"2014","unstructured":"Hoadley KA, et al. Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell. 2014;158:929\u201344. \n                    https:\/\/doi.org\/10.1016\/j.cell.2014.06.049.","journal-title":"Cell"},{"key":"646_CR12","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/sj.cdd.4401914.","volume":"13","author":"F Murray-Zmijewski","year":"2006","unstructured":"Murray-Zmijewski F, Lane DP, Bourdon JC. p53\/p63\/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress. Cell Death Differ. 2006;13:962\u201372. \n                    https:\/\/doi.org\/10.1038\/sj.cdd.4401914.","journal-title":"Cell Death Differ"},{"key":"646_CR13","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/nrc3446.","volume":"13","author":"X Su","year":"2013","unstructured":"Su X, Chakravarti D, Flores ER. p63 steps into the limelight: crucial roles in the suppression of tumorigenesis and metastasis. Nat Rev Cancer. 2013;13:136\u201343. \n                    https:\/\/doi.org\/10.1038\/nrc3446.","journal-title":"Nat Rev Cancer"},{"key":"646_CR14","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.ajpath.2010.11.061.","volume":"178","author":"O Karni-Schmidt","year":"2011","unstructured":"Karni-Schmidt O, et al. Distinct expression profiles of p63 variants during urothelial development and bladder cancer progression. Am J Pathol. 2011;178:1350\u201360. \n                    https:\/\/doi.org\/10.1016\/j.ajpath.2010.11.061.","journal-title":"Am J Pathol"},{"key":"646_CR15","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/j.1442-2050.2012.01400.x.","volume":"26","author":"W Lai","year":"2013","unstructured":"Lai W, et al. Upregulated ataxia-telangiectasia group D complementing gene correlates with poor prognosis in patients with esophageal squamous cell carcinoma. Dis Esophagus. 2013;26:817\u201322. \n                    https:\/\/doi.org\/10.1111\/j.1442-2050.2012.01400.x.","journal-title":"Dis Esophagus"},{"key":"646_CR16","doi-asserted-by":"publisher","first-page":"5155","DOI":"10.1158\/0008-5472.CAN-15-0603.","volume":"75","author":"PL Palmbos","year":"2015","unstructured":"Palmbos PL, et al. ATDC\/TRIM29 drives invasive bladder cancer formation through miRNA-mediated and epigenetic mechanisms. Cancer Res. 2015;75:5155\u201366. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-0603.","journal-title":"Cancer Res"},{"key":"646_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063676.","volume":"8","author":"ZP Tang","year":"2013","unstructured":"Tang ZP, et al. Ataxia-telangiectasia Group D complementing gene (ATDC) promotes lung cancer cell proliferation by activating NF-\u03baB pathway. PLoS ONE. 2013;8:e63676. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0063676.","journal-title":"PLoS ONE"},{"key":"646_CR18","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ccr.2009.01.018","volume":"15","author":"L Wang","year":"2009","unstructured":"Wang L, et al. Oncogenic function of ATDC in pancreatic cancer through Wnt pathway activation and beta-catenin stabilization. Cancer Cell. 2009;15:207\u201319. S1535-6108(09)00027-0 [pii] 10.1016\/j.ccr.2009.01.018.","journal-title":"Cancer Cell"},{"key":"646_CR19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1101\/gad.253591.114.","volume":"29","author":"L Wang","year":"2015","unstructured":"Wang L, et al. ATDC induces an invasive switch in KRAS-induced pancreatic tumorigenesis. Genes Dev. 2015;29:171\u201383. \n                    https:\/\/doi.org\/10.1101\/gad.253591.114.","journal-title":"Genes Dev"},{"key":"646_CR20","first-page":"5053","volume":"8","author":"F Qiu","year":"2015","unstructured":"Qiu F, Xiong JP, Deng J, Xiang XJ. TRIM29 functions as an oncogene in gastric cancer and is regulated by miR-185. Int J Clin Exp Pathol. 2015;8:5053\u201361.","journal-title":"Int J Clin Exp Pathol"},{"key":"646_CR21","doi-asserted-by":"publisher","first-page":"21541","DOI":"10.1074\/jbc.M116.730960.","volume":"291","author":"M D\u00fckel","year":"2016","unstructured":"D\u00fckel M, et al. The breast cancer tumor suppressor TRIM29 is expressed via ATM-dependent signaling in response to hypoxia. J Biol Chem. 2016;291:21541\u201352. \n                    https:\/\/doi.org\/10.1074\/jbc.M116.730960.","journal-title":"J Biol Chem"},{"key":"646_CR22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s13402-016-0312-6.","volume":"40","author":"GC Guo","year":"2017","unstructured":"Guo GC, Wang JX, Han ML, Zhang LP, Li L. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression. Cell Oncol. 2017;40:157\u201366. \n                    https:\/\/doi.org\/10.1007\/s13402-016-0312-6.","journal-title":"Cell Oncol"},{"issue":"12","key":"646_CR23","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/ng.2798","volume":"45","author":"Guangwu Guo","year":"2013","unstructured":"Guo, G et al. Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation. Nat Genet. \n                    https:\/\/doi.org\/10.1038\/ng.2798\n                    \n                   (2013).","journal-title":"Nature Genetics"},{"key":"646_CR24","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095.","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2:401\u20134. \n                    https:\/\/doi.org\/10.1158\/2159-8290.CD-12-0095.","journal-title":"Cancer Discov"},{"key":"646_CR25","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088.","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6:pl1 \n                    https:\/\/doi.org\/10.1126\/scisignal.2004088.","journal-title":"Sci Signal"},{"key":"646_CR26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3233\/BLC-170144","volume":"4","author":"S Tamura","year":"2018","unstructured":"Tamura S. et al. Molecular correlates of in vitro responses to dacomitinib and afatinib in bladder cancer. Bladder Cancer. 2018;4:77\u201390.","journal-title":"Bladder Cancer"},{"issue":"6","key":"646_CR27","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.eururo.2018.06.047","volume":"74","author":"Daniel H. Hovelson","year":"2018","unstructured":"Hovelson, DH et al. Targeted DNA and RNA sequencing of paired urothelial and squamous bladder cancers reveals discordant genomic and transcriptomic events and unique therapeutic implications. Eur Urol. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2018.06.047\n                    \n                   (2018).","journal-title":"European Urology"},{"key":"646_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030206.","volume":"7","author":"W Choi","year":"2012","unstructured":"Choi W, et al. p63 expression defines a lethal subset of muscle-invasive bladder cancers. PLoS ONE. 2012;7:e30206 \n                    https:\/\/doi.org\/10.1371\/journal.pone.0030206.","journal-title":"PLoS ONE"},{"key":"646_CR29","doi-asserted-by":"publisher","first-page":"7190","DOI":"10.1093\/nar\/gks389.","volume":"40","author":"SS McDade","year":"2012","unstructured":"McDade SS, et al. Genome-wide analysis of p63 binding sites identifies AP-2 factors as co-regulators of epidermal differentiation. Nucleic Acids Res. 2012;40:7190\u2013206. \n                    https:\/\/doi.org\/10.1093\/nar\/gks389.","journal-title":"Nucleic Acids Res"},{"key":"646_CR30","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1101\/gr.229102.","volume":"12","author":"WJ Kent","year":"2002","unstructured":"Kent WJ, et al. The human genome browser at UCSC. Genome Res. 2002;12:996\u20131006. \n                    https:\/\/doi.org\/10.1101\/gr.229102.\n                    \n                  . Article published online before print in May 2002.","journal-title":"Genome Res"},{"key":"646_CR31","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/sj.cdd.4401926.","volume":"13","author":"E Candi","year":"2006","unstructured":"Candi E, et al. Differential roles of p63 isoforms in epidermal development: selective genetic complementation in p63 null mice. Cell Death Differ. 2006;13:1037\u201347. \n                    https:\/\/doi.org\/10.1038\/sj.cdd.4401926.","journal-title":"Cell Death Differ"},{"key":"646_CR32","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1016\/j.bbamcr.2015.05.035.","volume":"1853","author":"Y Masuda","year":"2015","unstructured":"Masuda Y, Takahashi H, Hatakeyama S. TRIM29 regulates the p63-mediated pathway in cervical cancer cells. Biochim Biophys Acta. 2015;1853:2296\u2013305. \n                    https:\/\/doi.org\/10.1016\/j.bbamcr.2015.05.035.","journal-title":"Biochim Biophys Acta"},{"key":"646_CR33","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/j.cell.2013.11.029.","volume":"155","author":"KJ Cheung","year":"2013","unstructured":"Cheung KJ, Gabrielson E, Werb Z, Ewald AJ. Collective invasion in breast cancer requires a conserved basal epithelial program. Cell. 2013;155:1639\u201351. \n                    https:\/\/doi.org\/10.1016\/j.cell.2013.11.029.","journal-title":"Cell"},{"issue":"12","key":"646_CR34","doi-asserted-by":"publisher","first-page":"4314","DOI":"10.1083\/jcb.201712130","volume":"217","author":"Fengrong Wang","year":"2018","unstructured":"Wang, F, Chen, S, Liu, HB, Parent, CA, Coulombe. PA Keratin 6 regulates collective keratinocyte migration by altering cell\u2013cell and cell\u2013matrix adhesion. J Cell Biol. \n                    https:\/\/doi.org\/10.1083\/jcb.201712130\n                    \n                   (2018).","journal-title":"The Journal of Cell Biology"},{"key":"646_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/srep24389.","volume":"6","author":"C Velez-delValle","year":"2016","unstructured":"Velez-delValle C, Marsch-Moreno M, Castro-Munozledo F, Galvan-Mendoza IJ, Kuri-Harcuch W. Epithelial cell migration requires the interaction between the vimentin and keratin intermediate filaments. Sci Rep. 2016;6:24389 \n                    https:\/\/doi.org\/10.1038\/srep24389.","journal-title":"Sci Rep"},{"key":"646_CR36","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.3892\/or.2016.4941.","volume":"36","author":"W Xu","year":"2016","unstructured":"Xu W, et al. RNA interference against TRIM29 inhibits migration and invasion of colorectal cancer cells. Oncol Rep. 2016;36:1411\u20138. \n                    https:\/\/doi.org\/10.3892\/or.2016.4941.","journal-title":"Oncol Rep"},{"key":"646_CR37","doi-asserted-by":"publisher","unstructured":"Wang, Y, Day, ML, Simeone, DM, Palmbos, PL. 3-D cell culture system for studying invasion and evaluating therapeutics in bladder cancer. J Vis Exp. \n                    https:\/\/doi.org\/10.3791\/58345\n                    \n                   (2018).","DOI":"10.3791\/58345"},{"key":"646_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2017.03.030.","author":"R Seiler","year":"2017","unstructured":"Seiler R, et al. Impact of molecular subtypes in muscle-invasive bladder cancer on predicting response and survival after neoadjuvant chemotherapy. Eur Urol. 2017. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2017.03.030.","journal-title":"Eur Urol"},{"key":"646_CR39","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1084\/jem.20141601.","volume":"212","author":"SH Lee","year":"2015","unstructured":"Lee SH, et al. The Dishevelled-binding protein CXXC5 negatively regulates cutaneous wound healing. J Exp Med. 2015;212:1061\u201380. \n                    https:\/\/doi.org\/10.1084\/jem.20141601.","journal-title":"J Exp Med"},{"key":"646_CR40","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1128\/MCB.01023-09","volume":"30","author":"Z Yuan","year":"2010","unstructured":"Yuan Z, et al. The ATDC (TRIM29) protein binds p53 and antagonizes p53-mediated functions. Mol Cell Biol. 2010;30:3004\u201315. MCB.01023-09 [pii] 10.1128\/MCB.01023-09.","journal-title":"Mol Cell Biol"},{"key":"646_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041742.","volume":"7","author":"BH Cai","year":"2012","unstructured":"Cai BH, et al. p53 acts as a co-repressor to regulate keratin 14 expression during epidermal cell differentiation. PLoS ONE. 2012;7:e41742. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0041742.","journal-title":"PLoS ONE"},{"key":"646_CR42","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.pathol.2016.05.008.","volume":"48","author":"MZ Leivo","year":"2016","unstructured":"Leivo MZ, Elson PJ, Tacha DE, Delahunt B, Hansel DE. A combination of p40, GATA-3 and uroplakin II shows utility in the diagnosis and prognosis of muscle-invasive urothelial carcinoma. Pathology. 2016;48:543\u20139. \n                    https:\/\/doi.org\/10.1016\/j.pathol.2016.05.008.","journal-title":"Pathology"},{"key":"646_CR43","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.juro.2014.10.098.","volume":"193","author":"JM Gaya","year":"2015","unstructured":"Gaya JM, et al. \u0394Np63 expression is a protective factor of progression in clinical high grade T1 bladder cancer. J Urol. 2015;193:1144\u201350. \n                    https:\/\/doi.org\/10.1016\/j.juro.2014.10.098.","journal-title":"J Urol"},{"key":"646_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2017.149.","author":"AL Han","year":"2017","unstructured":"Han AL, et al. Fibulin-3 promotes muscle-invasive bladder cancer. Oncogene. 2017. \n                    https:\/\/doi.org\/10.1038\/onc.2017.149.","journal-title":"Oncogene"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41388-018-0646-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-018-0646-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-018-0646-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:14:56Z","timestamp":1684617296000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-018-0646-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,14]]},"references-count":44,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["646"],"URL":"https:\/\/doi.org\/10.1038\/s41388-018-0646-9","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,14]]},"assertion":[{"value":"9 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}